Safety, tolerability of Kinesio Taping in patients with arm lymphedema assessed
the ONA take:
Kinesio Tex Gold bandage by the Kinesio Taping (KT) technique proved to be safe and tolerable in patients with lymphedema, and resulted in improved functionality and no change of the affected limb volume, according to a new study published online ahead of print in the journal Supportive Care in Cancer.
For the study, researchers enrolled 24 women with with cancer and arm lymphedema. Clinicians applied Kinesio Tex Gold bandage by the KT technique to patients.
All participants were assessed for limb volume and functionality before and 4 days after the intervention, skin disorders, and reported tolerance.
Results showed that no participants had cutaneous lesions, vesicle, or limb hyperthermia. Of the 24 patients, 4.2% presented skin peeling and redness.
The majority of patients reported to impact on social life and they felt safer performing daily activities. There was a significant improvement of upper limb functionality after the intervention and no difference in limb volume was observed.
Kinesio Tex Gold bandage proved to be safe and tolerable in patients with lymphedema, and resulted in improved functionality.
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- Ruxolitinib: A Targeted Treatment Option for Patients with Polycythemia Vera
- Incontinence Affects QOL for Survivors of Gynecologic Cancers
- Adding Bevacizumab to Adjuvant Capecitabine Not Effective for mCRC
- ASCO, ASTRO Issue Guideline Update for Postmastectomy RT
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- Ruxolitinib Effective as Long-term Treatment Option for Polycythemia Vera
- Definitive IMRT Associated With Shorter Feeding Tube Placement Duration in HNC
- SBRT Improves Overall and Disease-Specific Survival in Stage I NSCLC
- Patients Receiving RT in APBI Facilities Despite Eligibility for Observation
- Prolonged Imatinib Therapy Improves Likelihood of Deeper Molecular Response
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|